Norman Selby

About

Norman Selby is the executive chairman of two innovative healthcare information businesses: Real Endpoints llc and Physicians Interactive, Inc. In addition, Selby serves as a senior advisor to Perseus llc, a private equity firm. Before joining Perseus in 2005, Selby was president and chief executive officer of TransForm Pharmaceuticals, Inc., a specialty pharmaceutical company which was acquired by Johnson & Johnson. He was also an executive vice president at Citigroup/Citicorp from 1997 to 2000. Selby spent most of his career at McKinsey & Company, where he was a senior partner and head of the firm's Global Pharmaceuticals and Medical Products practice. Selby serves on the Board of Trustees of the Central Park Conservancy, the Memorial Sloan-Kettering Cancer Center and the Ralph Lauren Center for Cancer Care and Prevention. In addition, he serves on the Board of Directors for Metamark Genetics and Merz Group GmbH. He is also a member of the advisory board of the Harvard Business

Investment Focus